Reckitt Benckiser Group (LON:RKT – Free Report) had its target price cut by Berenberg Bank from GBX 5,647 to GBX 5,479 in a report issued on Tuesday morning, Marketbeat.com reports. They currently have a hold rating on the stock.
A number of other analysts also recently issued reports on the stock. Citigroup assumed coverage on shares of Reckitt Benckiser Group in a report on Wednesday, January 14th. They set a “buy” rating and a GBX 7,000 price target on the stock. Jefferies Financial Group raised their target price on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 5,700 and gave the stock a “hold” rating in a research note on Wednesday, January 7th. JPMorgan Chase & Co. lifted their target price on Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the company a “neutral” rating in a research note on Wednesday, November 26th. Finally, Royal Bank Of Canada downgraded shares of Reckitt Benckiser Group to a “sector perform” rating and reduced their price target for the company from GBX 6,400 to GBX 6,200 in a report on Wednesday, January 14th. Three analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Reckitt Benckiser Group presently has an average rating of “Hold” and a consensus target price of GBX 6,268.43.
Read Our Latest Stock Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Down 0.4%
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its earnings results on Thursday, March 5th. The company reported £122.58 earnings per share (EPS) for the quarter. Reckitt Benckiser Group had a return on equity of 38.45% and a net margin of 25.23%. On average, analysts forecast that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current fiscal year.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
